Bluebird Ventures
Venture capitalPalo Alto · Seed–Series B · 1 people tracked
Also known as BLUEBIRD VENTURES GP I, LLC
Investment thesis
Bluebird Ventures focuses on helping founders and entrepreneurs advance medical science within a start-up setting. The firm believes individuals with sufficient passion, intellect, grit, and commitment can make a meaningful difference in the world. It emphasizes that strong management teams, rather than investors, build successful companies, positioning itself as a supportive partner to entrepreneurs pursuing progress in the medical and life sciences space.
Source: firm website, verified Aug 25, 2026.
Team · 1 people
from public directories
What they invest in
from 9 of 13 portfolio companiesBiotech ×9Healthtech ×6Medical Devices ×2AI & Machine Learning ×1Crypto & Web3 ×1Deep Tech ×1
HQs:United States×7Netherlands×1
Investments · 13 tracked
founders shown can be your intro pathBy year:2024 · 12021 · 12 dated
GRAIL develops the Galleri blood test for multi-cancer early detection using next-generation sequencing and machine learning to screen for multiple deadly cancer types before symptoms appear.
AI & Machine LearningBiotechHealthtechMedical DevicesMenlo Park, US
Jeffrey T. Huber(Director)Joshua Ofman, MD, MSHS(Chief Executive Officer)Aaron Freidin(Executive Officer)Josh Ofman(Executive Officer)Robert Ragusa(Executive Officer, Director)Jennifer Cook(Executive Officer, Director)
PartnerJeffrey Bird· solo GP
Co-investorsAmino CapitalARCH Venture PartnersBezos ExpeditionsDecheng CapitalDentsu VenturesFelicis Ventures+8 more
Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission.
BiotechDeep TechHealthtechLeiden, NL
Koenraad Wiedhaup(Founder & Chief Executive Officer)inRonald Brus(Founder & Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)inDinko Valerio(Founder and Chair of the Supervisory Board)Jintanat Ananworanich(Chief Medical Officer)Clarissa Koch(Chief Scientific Officer)
Co-investorsClavystBioF-Prime CapitalGV (Google Ventures)Casdin CapitalEuropean Innovation Council FundEuropean Investment Bank+5 more
Epirium Bio develops novel oral therapeutics targeting mitochondrial dysfunction and muscle diseases, particularly muscular dystrophy.
BiotechMedical DevicesSan Diego, US
Pam Taub(M.D., FACC, Founder)Alan Maisel(M.D., Founder)Francisco Villarreal(M.D., Ph.D., Founder)Jonathan Taub(Founder, Chief Executive Officer)Guillermo Ceballos(M.D., Founding Scientist)Russell J. Cox(President and CEO)
PartnerJeffrey Bird· solo GP
Co-investorsBroadview VenturesLongitude Capital
Forty Seven Inc was a clinical-stage immuno-oncology company developing antibody therapies targeting CD47, a "don't eat me" signal exploited by cancer cells, with lead candidate magrolimab.
BiotechHealthtechPalo Alto, US
Christopher Schaepe(Director)Dennis Henner(Director)Ravindra Majeti(Director)Eric Jensen(Executive Officer)Irving Weissman(Director)
BoardJeffrey Bird(Director)
PartnerJeffrey Bird· solo GP
Co-investorsLightspeed Venture PartnersSofinnova Ventures
PartnerJeffrey Bird· solo GP
Kriya Therapeutics is a biopharmaceutical company that develops and manufactures one-time gene therapies aimed at treating prevalent chronic diseases.
BiotechHealthtechMorrisville, US
Shankar Ramaswamy(Co-Founder, Chairman & CEO)inRoger Jeffs(Co-Founder & Vice Chairman)Fraser Wright(Scientific Co-Founder & Chief Gene Therapy Officer)inShankar Ramaswamy, M.D.(Founder)inMichele Stone(Chief Scientific Officer)Katherine Eade(Chief Legal Officer)
PartnerJeffrey Bird· solo GP
Co-investorsPatient Square CapitalPremji InvestAmplo VenturesForesite CapitalJDRF T1D FundNarya Capital+2 more
Medikine engineers cytokine mimetics — peptide-based therapeutics that mimic natural cytokines — to treat serious diseases, with a focus on immuno-oncology.
BiotechHealthtech
William J. Dower(PhD)Michael C. Needels(PhD)Ronald W. Barrett(PhD)Joseph Leveque(MD, CEO)
PartnerJeffrey Bird· solo GP
Faction is a venture capital firm that invests in cryptocurrency and blockchain projects at the seed and series A stages, focusing on entrepreneurs building fundamental utility across the technology stack.
BiotechCrypto & Web3New York, US
Oren Harnevo(Executive Officer, Director)Ronald Bianchini, Jr.(Executive Officer, Director)Roneil Rumburg(Cofounder)Ohad Finkelstein(Director)Christina Calvaneso(Executive Officer)Brian Pozesky(Executive Officer)
PartnerJeffrey Bird· solo GP
Co-investorsAccelAdaverseAlephAxeleo CapitalBright Pixel CapitalCapitalG+36 more
RNA therapeutics company with a chip-based mRNA manufacturing platform; acquired by Medici Therapeutics in November 2025.
BiotechEmeryville, US
Igor Khandros(Executive Officer, Director)
PartnerJeffrey Bird· solo GP
Co-investors+ND CapitalARCH Venture Partners
Pharmaceutical company acquired by Alexion in 2020.
PartnerJeffrey Bird· solo GP
Co-investorsLightstone VenturesProspect Venture Partners
PartnerJeffrey Bird· solo GP
Co-investorsScientific Health DevelopmentTexas Ventures
BiotechHealthtechHouston, US
Reynolds, III M. Delagado(Director)Benjamin A Hertzog(Executive Officer, Director)Jason J Heuring(Executive Officer)Benjamin A. Hertzog(President & CEO)Bryan E. Nearn(Vice President)
BoardLeo III E Linbeck(Director)
Co-investorsFannin Goldenrod HoldingsScientific Health Development
Pioneer in non-invasive prenatal testing, sold to Illumina in 2013.
PartnerJeffrey Bird· solo GP
Exits · 3
IPOs and acquisitions across the tracked portfolioGRAILNASDAQ: GRALForty Seven Incacq. by GileadPortola Pharmaceuticalsacq. by Alexion
Portfolio news
latest coverage across their companies
GRAIL · simplywall.st · Jul 17, 2026
Nominal · medicalbuyer.co.in · Jul 14, 2026
Leyden Labs · firstwordpharma.com · Jun 29, 2026
Kriya Therapeutics · nasdaqprivatemarket.com · Apr 3, 2026
Nutcracker Therapeutics · businessmodelcanvastemplate.com · Jul 11, 2025
Frequently asked questions
- How many investments has Bluebird Ventures made?
- Bluebird Ventures has 11 tracked investments, 4 of which have exited via acquisition or IPO.
- What stage does Bluebird Ventures invest at?
- Bluebird Ventures invests at the Seed, Series A, Series B stages.
- What sectors does Bluebird Ventures focus on?
- Bluebird Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Bluebird Ventures located?
- Bluebird Ventures is headquartered in Palo Alto, US.
- Who does Bluebird Ventures co-invest with?
- Bluebird Ventures most often shares deals with ARCH Venture Partners, Foresite Capital, Lightspeed Venture Partners, among 61 tracked co-investors.
Co-investors · 6
Lightspeed is a global venture capital firm that has spent over two decades backing innovative companies as an early and first investor.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
F-Prime Capital is an early-stage-focused investment firm backing companies across life sciences, technology, healthtech and services, and crypto.
Casdin Capital is an investment firm focused on the life sciences, investing across healthcare, biotechnology, synthetic biology, and related technology.
Maverick Capital is an investment management firm operating a unified platform of hedged and long strategies, serving both public and private investors since launching its first long/short equity fund in 1993.
Firms observed investing alongside Bluebird Ventures, from public investor directories. Shared companies are the overlap with Bluebird Ventures's recorded portfolio.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.